The story of Viagra, originally marketed by copyright, presents a complex case study for backers considering the pharmaceutical landscape . Despite its groundbreaking success and generation of billions in revenue , the intellectual property expiration has opened the floodgates for alternative medications, substantially diminishing profit potential